Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey
dc.authorid | Yildiz Kaya, Sibel/0000-0002-6319-7889 | |
dc.contributor.author | Tabak, F. | |
dc.contributor.author | Cuvalci, N. O. | |
dc.contributor.author | Kurtaran, B. | |
dc.contributor.author | Onlen, Y. | |
dc.contributor.author | Sari, N. D. | |
dc.contributor.author | Kaya, S. | |
dc.contributor.author | Ince, N. | |
dc.date.accessioned | 2024-09-18T21:01:53Z | |
dc.date.available | 2024-09-18T21:01:53Z | |
dc.date.issued | 2018 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description | International Liver Congress (ILC) -- APR 11-15, 2018 -- Paris, FRANCE | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | European Assoc Study Liver | en_US |
dc.identifier.doi | 10.1016/S0168-8278(18)30814-6 | |
dc.identifier.endpage | S298 | en_US |
dc.identifier.issn | 0168-8278 | |
dc.identifier.issn | 1600-0641 | |
dc.identifier.startpage | S297 | en_US |
dc.identifier.uri | https://doi.org/10.1016/S0168-8278(18)30814-6 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/13064 | |
dc.identifier.volume | 68 | en_US |
dc.identifier.wos | WOS:000461068601206 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Journal of Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Effectiveness and safety of direct-acting antiviral therapies in chronic hepatitis C infections patients with cirrhosis in Turkey | en_US |
dc.type | Conference Object | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1